NCT03342664

MIND: Artemis in the Removal of Intracerebral Hemorrhage

MIND: A Prospective, Multicenter Study of Artemis a Minimally Invasive Neuro Evacuation Device, in the Removal of Intracerebral Hemorrhage

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 236 (actual)
• Sponsor: Penumbra Inc. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Device to best medical management for the treatment of intracerebral hemorrhage (ICH).

Conditions

• Cerebral Hemorrhage
• Brain Hemorrhage
• Cerebral Parenchymal Hemorrhage
• Intracerebral Hemorrhage

Interventions

Type	Name	Description
DEVICE	Artemis + Medical Management	Subject will receive best MM in addition to the MIS procedure with Artemis.
OTHER	Best Medical Management Alone (MM)	Subject will receive best MM for ICH as determined by stroke physician following AHA/ESO guidelines.

Timeline

• Start date: 2018-02-06
• Primary completion: 2024-02-20
• Completion: 2024-09-23
• First posted: 2017-11-17
• Last updated: 2026-01-30
• Results posted: 2026-01-30

Locations

33 sites across 4 countries: United States, Austria, Canada, Germany

Regulatory

• FDA-regulated device study